EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Computational and Experimental Development of a Novel Multi‐Epitope Vaccine Candidate Against Bovine Leukaemia Virus

Yasaman Dini, Tohid Piri-Gharaghie iD, Elahe Hamdi, Pegah Goodarzi, Ronak Ahmadi

Veterinary Medicine and Science · 2026

DOI: 10.1002/vms3.71074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Medicine and Science, 2026. Verfasst von Yasaman Dini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Biological Science, Babol University of Medical Science, Babol, Iran. Hauptthemen laut MEDLINE: Leukemia Virus, Bovine, Enzootic Bovine Leukosis, Viral Vaccines, Epitopes, T-Lymphocyte. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: public, commercial.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bovine leukaemia virus (BLV) is the causative agent of enzootic bovine leukosis, a chronic infectious disease that causes significant economic losses in the dairy and beef industries worldwide. Despite extensive research, there is no licensed vaccine available for effective prevention and control of BLV infection.

Objectives

This study aimed to design and evaluate a novel multi‐epitope vaccine candidate against BLV using an integrated computational and experimental approach to enhance immunogenicity, expression efficiency, and molecular stability.

Methods

Major BLV structural proteins (gp51, gp30, and p24) were analyzed for B‐ and T‐cell epitope prediction using immunoinformatics tools. Selected epitopes were assembled into a single chimeric construct with appropriate linkers and an N‐terminal β‐defensin adjuvant. The vaccine was evaluated for antigenicity, allergenicity, and physicochemical properties. Structural modelling, molecular docking with Toll‐like receptors (TLRs), and RNA stability analyses were performed to assess receptor binding affinity and translational efficiency. Codon optimization for Lactococcus lactis expression was conducted using the JCAT server, and in silico cloning was verified in the NICE pNZ8148 vector.

Results

The designed vaccine showed high antigenicity (VaxiJen score: 0.7261), non‐allergenicity, and stability, with an optimal codon adaptation index (0.94) and GC content (48.55%). Molecular docking revealed strong interactions with TLR9 ( z ‐score = –2.5; van der Waals energy = −56.5 ± 3.8 kcal/mol), suggesting effective immune receptor engagement. RNAfold analysis indicated a stable mRNA structure (MFE = –155.20 kcal/mol), supporting efficient expression.

Conclusions

The multi‐epitope vaccine candidate demonstrated favourable immunological, structural, and translational properties, indicating its strong potential as a next‐generation recombinant vaccine against BLV. Further in vitro and in vivo validation is warranted to confirm its immunogenicity and protective efficacy in cattle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia Virus, BovineEnzootic Bovine LeukosisViral VaccinesEpitopes, T-LymphocyteEpitopesAnimalsCattleImmunoinformaticsEpitopes, B-LymphocyteVaccine DevelopmentProtein Subunit VaccinesMolecular Docking Simulation

Stichwörter der Autor:innen

Lactococcus lactisbovine leukaemia viruscodon optimizationimmunoinformaticsmolecular dockingmulti‐epitope vaccine

Substanzen

Viral VaccinesEpitopes, T-LymphocyteEpitopes, B-LymphocyteEpitopesProtein Subunit Vaccines

Autor:innen und Institutionen

  • Department of Biology, Faculty of Biological Science, Babol University of Medical Science, Babol, Iran.
  • Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
  • Department of Microbiology, Faculty of Basic Sciences, East Tehran Branch, Islamic Azad University, Tehran, Iran.
  • Department of Veterinary, Faculty of Veterinary Medicine, Ka.C., Islamic Azad University, Karaj, Iran.
  • Department of Veterinary, Faculty of Veterinary Medicine, Islamic Azad University of Tabriz, Tabriz, Iran.

ORCID-Profile: Tohid Piri-Gharaghie

Förderung

  • public, commercial

Zitieren

APA

Dini, Y., Piri-Gharaghie, T., Hamdi, E., Goodarzi, P., & Ahmadi, R. (2026). Computational and Experimental Development of a Novel Multi‐Epitope Vaccine Candidate Against Bovine Leukaemia Virus. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.71074

Vancouver

Dini Y, Piri-Gharaghie T, Hamdi E, Goodarzi P, Ahmadi R. Computational and Experimental Development of a Novel Multi‐Epitope Vaccine Candidate Against Bovine Leukaemia Virus. Veterinary Medicine and Science. 2026. doi:10.1002/vms3.71074

BibTeX
@article{Dini2026,
  author = {Dini, Yasaman and Piri-Gharaghie, Tohid and Hamdi, Elahe and Goodarzi, Pegah and Ahmadi, Ronak},
  title = {Computational and Experimental Development of a Novel Multi‐Epitope Vaccine Candidate Against Bovine Leukaemia Virus},
  journal = {Veterinary Medicine and Science},
  year = {2026},
  doi = {10.1002/vms3.71074}
}
Kostenlos starten →